ME THERAPEUTICS HOLDINGS INC.

VANCOUVER, A1 · Founded 2021 · CIK 0001990555 · Biotech · Private

Immuno-oncology therapeutics that reprogram immune cells to treat cancer

metherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3K
1 Form D · Aug 2023
37 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,350
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2197Conagen inc——
2198SPHEREBIO, INC.——
2199Egaceutical Corp—$9K
2200ME THERAPEUTICS HOLDINGS INC.—$3K
2201NEONEURON, LLC——
2202PEPTIFORGE, INC——
2203BIOPROCESSING INNOVATIVE COMPANY INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Salim DhanjiDirector · Executive Officer
  • Kenneth HarderDirector
  • Jamil KassamExecutive Officer
  • Quinn MartinExecutive Officer
  • Karim NanjiDirector
  • John PriatelDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.